Organovo Announces Phase 2 Results For FXR314; Says 'Study Subjects Receiving FXR314 Achieved Statistically Significant Reduction in Liver Fat Content From Baseline'
Organovo 公布了 FXR314 的第 2 阶段结果;表示 “接受 FXR314 的研究受试者肝脏脂肪含量比基准线减少了统计学上的显著性”
Organovo Announces Phase 2 Results For FXR314; Says 'Study Subjects Receiving FXR314 Achieved Statistically Significant Reduction in Liver Fat Content From Baseline'
Organovo 公布了 FXR314 的第 2 阶段结果;表示 “接受 FXR314 的研究受试者肝脏脂肪含量比基准线减少了统计学上的显著性”
使用浏览器的分享功能,分享给你的好友吧